1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On July 9, 2026, Licensing Program Analyst, Arvin Villanueva (LPA), conducted an unannounced case management visit at this facility. LPA met with administrator, Elvis Flores (AD), and explained the purpose of the visit. The purpose of the visit is to address facility action report (FAR) prepared by Alta Regional Center dated March 25, 2026. Present during this visit were four clients in care with two staff on duty. The licensee, Joanna Flores, arrived shortly after.
Per FAR, ACRC representative conducted a review of the client’s medication records and corresponding medication supply. Documentation signed by the client’s physician indicated that Medication-1 (M1) 250 mg, previously ordered for administration every Monday, Wednesday, and Friday, was discontinued effective 02/12/2026.
A review of the Medication Administration Record (MAR) confirmed that facility staff accurately reflected the discontinuation and did not administer the medication during the March 2026 medication cycle. Despite appropriate MAR documentation, inspection of the client’s March bubble pack revealed that M1 tablets remained present.
According to the report, AD reported that a request had been made to the pharmacy to remove the discontinued medication from the bubble pack. The pharmacy declined, stating that bubble packs could not be altered after packaging. As a result, staff have been manually removing M1 tablets from the bubble pack, placing them into a separate Ziploc bag, and storing them apart from the client’s currently active medications.
{1 of 2}
|